TrialDigestive diseases and sciences2022

Efficacy and Safety of Antofloxacin-Based Triple Therapy for Helicobacter pylori Eradication Failure in China.

Xiao-Jian He et al.PubMed ↗Publisher ↗

No numbers read from the abstract.